Want to see SE:VICO full AI Analyst Report?
Vicore Pharma Holding AB (VICO) Financial Statements
Vicore Pharma Holding AB Financial Overview
Vicore Pharma Holding AB's market cap is currently $2.73B. The company's EPS TTM is $-1.92; its P/E ratio is -5.05; Vicore Pharma Holding AB is estimated to report earnings on November 5, 2026, and the estimated EPS forecast is $-0.51. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 3.82M | $ 109.35M | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 3.82M | $ 109.35M | $ -3.42M | $ -3.61M | $ -3.60M |
| Operating Income | $ -454.44M | $ -194.19M | $ -321.51M | $ -290.73M | $ -294.82M |
| EBITDA | $ -477.41M | $ -166.64M | $ -317.47M | $ -286.20M | $ -289.82M |
| Net Income | $ -477.47M | $ -168.63M | $ -310.94M | $ -288.42M | $ -296.48M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.17B | $ 1.16B | $ 482.66M | $ 261.74M | $ 371.20M |
| Total Assets | $ 1.22B | $ 1.20B | $ 497.84M | $ 338.01M | $ 451.17M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 65.00K | $ 320.00K |
| Net Debt | $ -578.15M | $ -1.16B | $ -333.62M | $ -256.74M | $ -293.88M |
| Total Liabilities | $ 124.16M | $ 73.78M | $ 42.45M | $ 48.92M | $ 67.85M |
| Stockholders' Equity | $ 1.10B | $ 1.13B | $ 455.39M | $ 289.08M | $ 383.32M |
| Cash Flow | |||||
| Free Cash Flow | $ -375.74M | $ -164.95M | $ -448.62M | $ -302.92M | $ -265.17M |
| Operating Cash Flow | $ -374.44M | $ -164.95M | $ -249.58M | $ -299.92M | $ -265.17M |
| Investing Cash Flow | $ -601.81M | $ 149.04M | $ -144.46M | $ 74.00M | $ -7.00M |
| Financing Cash Flow | $ 430.54M | $ 834.06M | $ 470.86M | $ 187.04M | $ 318.18M |
Currency in SEK